Notice of Intent to Publish a Funding Opportunity Announcement (FOA) for The Rare Diseases Clinical Research Consortia (U54)
February 1, 2013
The Purpose of this Notice is to indicate the intent to publish a Funding Opportunity Announcement (FOA) to continue the Rare Diseases Clinical Research Network (RDCRN) Program and to alert potential applicants of the objectives of this cooperative agreement program. This FOA will be open to current Rare Diseases Clinical Research Consortia (RDCRC) as well as to new applicants. This Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects. The FOA is expected to be published in Spring 2013 with an expected application due date in Fall 2013. This FOA will utilize the U54 activity code. Details of the planned FOA are provided below.
See more information on this news item.
From the National Center for Advancing Translational Sciences
From the National Institutes of Health